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A genetic hierarchy of interactions, involving myogenic regulatory factors of the MyoD 
and myocyte enhancer-binding 2 (MEF2) families, serves to elaborate and maintain the 
differentiated muscle phenotype through transcriptional regulation of muscle-specific 
target genes. Much work suggests that members of the cysteine-rich protein (CRP) family 
of LIM domain proteins also play a role in muscle differentiation; however, the specific 
functions of CRPs in this process remain undefined. Previously, we characterized two 
members of the Drosophila CRP family, the muscle LIM proteins Mlp60A and Mlp84B, 
which show restricted expression in differentiating muscle lineages. To extend our 
analysis of Drosophila Mlps, we characterized the expression of Mlps in mutant back­
grounds that disrupt specific aspects of muscle development. We show a genetic require­
ment for the transcription factor dMEF2 in regulating Mlp expression and an ability of 
dMEF2 to bind, in vitro, to consensus MEF2 sites derived from those present in Mlp 
genomic sequences. These data suggest that the Mlp genes may be direct targets of 
dMEF2 within the genetic hierarchy controlling muscle differentiation. Mutations that 
disrupt myoblast fusion fail to affect Mlp expression. In later stages of myogenic differ­
entiation, which are dedicated primarily to assembly of the contractile apparatus, we 
analyzed the subcellular distribution of Mlp84B in detail. Immunofluorescent studies 
revealed the localization of Mlp84B to muscle attachment sites and the periphery of 
Z-bands of striated muscle. Analysis of mutations that affect expression of integrins and 
-actinin, key components of these structures, also failed to perturb Mlp84B distribution. 
In conclusion, w e have used molecular epistasis analysis to position Mlp function 
downstream of events involving mesoderm specification and patterning and concomi­
tant with terminal muscle differentiation. Furthermore, our results are consistent with a 
structural role for Mlps as components of muscle cytoarchitecture.
IN T R O D U C T IO N
Myogenesis involves a series of discrete processes be­
ginning with specification and proliferation of the me­
soderm, subdivision of functionally distinct muscle 
lineages, and ultimately, muscle differentiation. In ver­
tebrates, commitment to a skeletal muscle fate re­
quires the action of myogenic regulatory factors in­
cluding members of the MyoD basic helix-loop-helix
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(bHLH) family and the myocyte enhancer-binding 2 
(MEF2) proteins that influence muscle development 
through transcriptional regulation of muscle-specific 
target genes (for review, see Molkentin and Olson, 
1996; Yun and Wold, 1996). A  third family of proteins, 
the LIM domain-containing cysteine-rich proteins 
(CRPs), have also been implicated in promoting mus­
cle differentiation (Arber et al., 1997; Louis et al., 1997). 
The crucial involvement of CRPs in myogenic differ­
entiation has been confirmed by genetic studies in 
mice. Eliminating the function of one CRP family 
member, CRP3 (also called the muscle LIM protein
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MLP) results in postnatal lethality caused by heart 
failure that is associated with dilated cardiomyopathy 
and severe disruptions of cardiac muscle architecture 
(Arber et al., 1997).
Despite the dramatic consequences associated with 
loss of CRP3/M LP expression, the mechanistic details 
of CRP function in muscles remain speculative. Con­
troversy over the precise role of CRPs stems in part 
from the fact that CRP isoforms have been observed in 
cell nuclei and in association with the actin-based 
cytoskeleton (Arber et al., 1994; Arber and Caroni, 
1996; Crawford et al., 1994; Kong et al., 1997; Louis et 
al., 1997). Consistent with the hypothesis that CRP 
family members contribute to muscle differentiation 
by regulating the transcription of muscle structural 
genes, one study describes an interaction between 
CRP3/M LP and the bHLH transcription factor MyoD 
(Kong et al., 1997). Evidence for functionally relevant 
interactions between bHLH factors and LIM domain 
proteins has been established in other systems. For 
example, the hematopoietic bHLH transcription factor 
SCL (Tal1) controls erythroid differentiation in part 
through interactions with the nuclear LIM protein 
Lmo-2 (RBTN-2) (Valge-Archer et al., 1994; Wadman et 
al., 1997).
Other data are consistent with a structural role for 
CRP isoforms in muscle. In particular, CRPs are 
known to distribute along the actin cytoskeleton and 
at integrin-rich sites of adhesion in cultured fibroblasts 
and muscle cells (Sadler et al., 1992; Arber et al., 1994; 
Crawford et al., 1994). Moreover, two cytoskeletal pro­
teins, zyxin and -actinin, have been shown to interact 
directly with CRPs in a variety of biochemical assays 
(Sadler et al., 1992; Pomies et al., 1997). Zyxin, a protein 
displaying proline-rich sequences and three LIM do­
mains, has been implicated in the control of microfila­
ment dynamics (Golsteyn et al., 1997). a-Actinin, an 
actin cross-linking protein, is prominent in both non­
muscle and muscle cells; in the myofibril, -actinin 
localizes to Z-bands that define the ends of each sar- 
comeric unit (McKenna et al., 1986). Thus, via interac­
tions with cytoskeletal components, CRPs may con­
tribute to muscle differentiation as an integral part of 
muscle cytoarchitecture. In this context, it is notewor­
thy that the terminal phenotype of CRP3/MLP null 
mice is disorganization of cardiac muscle myofibrils 
(Arber et al., 1997). Clearly, additional work is neces­
sary to define more precisely the molecular mecha­
nism by which CRPs act in myogenesis.
The availability of a genetic system for defining the 
pathways that require CRP function could provide 
significant insight into the underlying mechanisms by 
which CRPs participate in myogenesis. Toward that 
end, two Drosophila CRP family members, termed 
muscle LIM proteins Mlp60A  and Mlp84B, have been 
identified (Arber et al., 1994; Stronach et al., 1996). 
Drosophila Mlps exhibit muscle-specific expression, ac­
cumulating in all of the body wall and visceral and 
pharyngeal muscles in the embryo. Analysis of the 
temporal expression profiles of Mlp60A  and Mlp84B 
transcripts during development pointed to a potential 
requirement for the proteins late in the muscle differ­
entiation process. Here, we have used molecular ep- 
istasis analysis to position the Mlps within the regu­
latory hierarchy that controls muscle development in 
Drosophila. Specifically, we have examined the expres­
sion and distribution of Mlps in the context of muta­
tions that are known to disrupt specific processes in 
the myogenic pathway. For instance, we have evalu­
ated the role of dMEF2, an essential myogenic tran­
scription factor (Bour et al., 1995; Lilly et al., 1995), in 
Mlp expression. We have also determined whether 
myoblast fusion, a key event in somatic muscle differ­
entiation, is required for Mlp accumulation. Finally, 
we analyzed at higher resolution the localization of 
Drosophila Mlp84B in various muscles at different 
stages of development and show that its localization is 
not dependent on two structural muscle proteins, 
-actinin or PS2 integrin receptors.
M A T E R IA L S  A N D  M E T H O D S
Drosophila Stocks and Crosses
AH flies were reared at 25°C unless otherwise noted on standard 
cornmeal agar food plus yeast. Canton-S served as wild-type stock. 
For analysis of dMEF2 mutant embryos, we used the mutation 
mef22-21, an ethyl methane sulfonate-induced null allele (Bour et al., 
1995). This allele was crossed into a w1118 background and balanced 
over a CyO chromosome carrying the lacZ gene under the control of 
the actin5C promoter (CyO-actinlZ), a gift from David VanVactor 
(Harvard Medical School, Boston, MA). The CyO-actinlZ balancer 
chromosome has been used previously to distinguish embryos car­
rying that chromosome from those that are homozygous for reces­
sive lethal loci (Bourgouin et al., 1992; Lundgren et al., 1995). In our 
experiments, embryos that inherit the balancer chromosome show 
expression of -galactosidase during most of embryogenesis; by 
immunocytochemistry, the protein is detected within the nuclei of 
many cells that are distributed throughout the internal space of the 
embryo. This particular staining pattern was absent in approxi­
mately one-fourth of embryos derived from the mef22-21/ CyO- 
actinlZ stock, thus allowing for the identification of homozygous 
dMEF2 null mutant embryos. Aiding our identification of dMEF2 
null embryos was the observation that only the portion of the 
population in which -galactosidase immunoreactivity was absent 
also showed morphological and muscle differentiation defects con­
sistent with loss of dMEF2 function.
For dMEF2 overexpression studies, we used w;GawB 69B, a ho­
mozygous viable enhancer trap line that expresses GAL4 in the 
epidermis at germ band extended stages (Brand and Perrimon,
1993). Males from this stock were crossed to virgins from the ho­
mozygous viable stock yw; UAS-MEF 1, which carries the dMEF2 
cDNA under the control of GAL4 target upstream activating sites 
(UASs) (Lin et al., 1997). All embryos derived from this cross ex­
pressed dMEF2 in the epidermis. For analysis of myoblast fusion, a 
severe rollingstone allele was used, rost23, balanced over the CyO 
chromosome (Paululat et al., 1995). Mutant embryos were recog­
nized by fusion defects. -Actinin mutant alleles used in this study 
include ethyl methane sulfonate-induced l(1)EA43 and l(1)EA82 and 
x-ray-induced l(1)HC288, l(1)HC207, and l(1)C212 (Perrimon et al., 
1985; Flybase, 1994). All of these alleles are larval lethal. Larvae from
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each stock were picked for midgut dissection. The integrin mutant 
stocks used were mysVFM4, carrying a null allele of the £iPS subunit 
(Flybase, 1994), and y v ifB4 f/FM6, carrying a null allele of the aPS2 
subunit (Brown, 1994). These mutant embryos were recognized by 
morphological criteria including their specific muscle defects.
Larval Midgut Preparation
Wild-type first or third instar larvae for dissection were picked out 
of Canton-S stock bottles. Hemizygous a-actinin mutant larvae were 
identified by their progressively paralyzed, flaccid phenotype 
among a population of developing larvae. Larvae were dissected, 
and midguts were processed as described (Saide et al., 1989). Pri­
mary antibodies were B50 (rabbit anti-Mlp84B) preabsorbed against 
early stage fixed embryos and diluted to 1:200 (Stronach et al., 1996) 
and 3A1 (mouse anti-a-actinin) culture supernatant diluted 1:2 
(Saide et al., 1989). Secondary antibodies were affinity-purified Texas 
Red-conjugated goat anti-mouse IgG and fluorescein-conjugated 
goat anti-rabbit IgG used at 1:250 (Cappel Laboratories, Durham, 
NC). Samples were viewed using confocal microscopy.
Figure 1. Schematic representation of the CRP family of LIM do­
main proteins. In vertebrates, there are three conserved isoforms, 
CRP1, CRP2, and CRP3/MLP, encoded by unique genes. AU share 
the same molecular architecture with two LIM domains, each fol­
lowed by short glycine-rich regions (black box). In Drosophila, there 
are two proteins related to the vertebrate CRPs. Mlp60A exhibits a 
single LIM-glycine motif. Mlp84B comprises five tandem LIM-gly- 
cine modules.
Fluorescent Embryo Staining and Confocal Analysis
For immunofluorescence, embryos were collected and fixed accord­
ing to standard procedures (Patel, 1994) except the Triton X-100 
concentration was raised to 0.3% in all wash and blocking buffers. In 
all cases, egg collections were performed for no more than 15 h to 
minimize the presence of older embryos with impermeable cuticles. 
The following antibodies and dilutions were used in this study: 
rabbit anti-Mlp60A (B49) at 1:250, rabbit anti-Mlp84B (B50) at 1:250­
500, rabbit anti-£i-galactosidase at 1:5000 (Cappel Laboratories), 
mouse anti-0PS (CF6G1 1 ) at 1:1000 (Brower et al., 1984), and rabbit 
anti-muscle myosin at 1:500 (Kiehart and Feghali, 1986). In the 
analysis of Mlp expression in dMEF2 mutant embryos, both primary 
antibodies (anti-Mlp and anti- -galactosidase) were derived from 
rabbit and thus were visualized using a single secondary antibody. 
Because the distributions of Mlps and -galactosidase are nonover­
lapping (our unpublished results), genotypes can be unambigu­
ously assigned based on the presence or absence of -galactosidase 
staining. All fluorochrome-conjugated secondary antibodies were 
obtained from either Cappel Laboratories or Jackson ImmunoRe- 
search Laboratories (West Grove, PA) and used at 1:250-500. Im­
ages of embryos were captured as described previously (Stronach et 
al., 1996). Images of visceral muscle were obtained using a 60X 
objective and represent 1- m-thick optical sections. For assessment 
of protein colocalization, we were cognizant of the alignment of 
tissue and degree of distortion in the Z dimension with respect to 
the axis of the laser during optical sectioning.
Genomic Sequence Analysis
For studying the genomic region comprising the Mlp84B gene, we 
first isolated clones from the Drosophila melanogaster genomic library 
"D.m. isox234" constructed in AEMBL3, a kind gift from John 
Tamkun (University of California, Santa Cruz, CA). Approximately
400,000 plaque-forming units were screened with the entire Mlp84B 
cDNA (Stronach et al., 1996) using standard techniques (Sambrook 
et al., 1989). Genomic sequence was obtained primarily from phage 
clone 4B2, because it fully spans the noncoding and coding portions 
of the Mlp84B transcript. Sequencing was performed by the DNA 
Sequencing Core Facility at the University of Utah using Mlp84B 
gene-specific primers. Either ABI dRhodamine dye terminators or 
ABI Prism BigDye terminators were used during cycle sequencing 
with Taq FS DNA polymerase. DNA sequence was collected and 
analyzed on an ABI Prism 377 automated DNA sequencer (Applied 
Biosystems, Foster City, CA). Approximately 5000 bp of sequence 
have been submitted to GenBank under accession number 
AF090832. Sequences were analyzed using DNASTAR software 
(DNASTAR, Madison, WI). The positions of each of the six regions
that exactly match the MEF2 consensus binding site (Olson et al., 
1995) are noted in the accession, as are four other sites that have a 
9/10 match to the consensus.
The genomic region comprising the Mlp60A gene was sequenced 
by the Berkeley Drosophila Genome Project (Celniker et al., unpub­
lished results) and obtained via GenBank accession number 
AC004642. A region of ~5000 bp constituting the gene was analyzed 
for potential MEF2 binding sites using the same criteria.
G el M obility Shift Assays
Gel mobility shift assays were performed with dMEF2 protein syn­
thesized using the Promega (Madison, WI) TNT rabbit reticulocyte 
lysate in vitro transcription and translation system (Lilly et al., 1994). 
For each 20-ftl reaction, 3 ftl of lysate containing PCite-dMEF2 or the 
control PCite vector alone were used. The lysates were incubated for 
10 min at room temperature with 1.5 jug of poly(dI-dC), 1X binding 
buffer (40 mM KCL, 15 mM HEPES, pH 7.9, 1 mM EDTA, 0.5 mM 
DTT, and 5% glycerol), and the indicated competitor oligonucleo­
tides. 32P-labeled probe (20,000 cpm) was then added and incubated 
for an additional 10 min before loading onto a 6% polyacrylamide 
gel in 0.5 X Tris borate-EDTA buffer. The competitor oligonucleo­
tides were added at 100-fold molar excess to the labeled probe. The 
sequences of the sense strand of the oligonucleotides used for 
probes and competitors were as follows (linker nucleotides added 
for end labeling are shown as lowercase): muscle creatine kinase 
(MCK) MEF2, gatcGCTCTAAAAATAACCCTGTCG; Mutant 6, 
gatcGCTCTAAACATAACCCTGTCG; Mlp60A-B, gatccGCCCCTC- 
TATTTATAGATATG; and Mlp84B-D, gatcCACTATTATTAATA- 
GATTCCG.
R E SU LT S
The CRP family of LIM domain proteins currently 
consists of three vertebrate isoforms, CRP1, CRP2, and 
CRP3/MLP, and two Drosophila members, Mlp60A 
and Mlp84B (Figure 1) (Weiskirchen and Bister, 1993; 
Weiskirchen et al., 1995; Arber et al., 1994; Crawford et 
al., 1994; Stronach et al., 1996; Louis et al., 1997). The 
vertebrate proteins share a common molecular archi­
tecture with two copies of the LIM domain, each fol­
lowed by a small glycine-rich segment. Although the 
Drosophila family members diverge in the number of 
LIM-glycine repeats, they show significantly high se­
quence identity (46- 60%) when compared with their
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Figure 2. The transcription factor dMEF2 is 
essential for Mlp expression. dMEF2 het­
erozygous embryos express Mlp60A (A) and 
Mlp84B (B) in somatic, visceral, and pharyn­
geal muscles. These embryos also carry the 
balancer chromosome from which the lacZ 
gene is expressed. Thus, by indirect immu­
nofluorescence, we detect not only Mlp ex­
pression in these embryos but expression of 
-galactosidase in single cells dispersed 
throughout the embryo (A and B, arrow­
heads). Mlp60A (C) and Mlp84B (D) fail to 
be expressed in the dMEF2 null mutant em­
bryos. Null embryos display defective mid­
gut morphology and no |3-galactosidase- 
positive cells. All panels show lateral views 
of stage 16 (13- to 16-h) embryos oriented 
with dorsal up and anterior to the left. Bar, 
50 ftm.
vertebrate relatives. Much work suggests that CRP 
fam ily members play an essential role in myogenic 
development by promoting muscle differentiation. 
Here, we address the potential requirements for 
Drosophila Mlps by positioning their function within 
a genetic regulatory hierarchy that controls myo- 
genesis.
Regulation o f Muscle LIM  Protein Expression by 
dMEF2
In Drosophila, the dMEF2 transcriptional regulator is 
essential for completion of myogenesis (Bour et al., 
1995; Lilly et al., 1995). dMEF2 null mutant embryos 
exhibit a failure of muscle differentiation, although 
muscle specification and patterning occur fairly nor­
mally. Targets of dMEF2 activity include muscle struc­
tural genes that encode components of the myofibril, 
such as myosin and tropomyosin (Bour et al., 1995; Lin 
et al., 1996). To assess whether Mlps are downstream 
of dMEF2 activity, we used indirect immunofluores­
cence to evaluate the expression of Mlp60A  and 
Mlp84B in dMEF2 mutant embryos. In heterozygous 
embryos, which express -galactosidase encoded by a 
lacZ gene carried on the balancer chromosome, Mlps 
are expressed appropriately in the muscles (Figure 2, 
A  and B; cf. Stronach et al., 1996). The Mlp expression 
pattern is quite distinct and exhibits no overlap with 
the expression of j3-galactosidase. Mlps are found ex­
clusively in muscle derivatives, whereas -galactosi- 
dase is detected in many internal nonmuscle cells 
(Figure 2, A  and B, arrowheads). Homozygous dMEF2 
null embryos were identified by morphological crite­
ria and by lack of staining for -galactosidase; they 
constituted ~ 25% of the total collected population. In 
the mutant embryos, neither Mlp60A  nor Mlp84B ex­
pression was detected in any tissue (Figure 2, C and
D). From the results presented here, we conclude that 
dMEF2 is an essential positive regulator of Mlp60A 
and Mlp84B expression. This lack of expression is 
notable given that it has been previously shown that 
mesoderm is formed and specified normally in dMEF2 
mutants (Bour et al., 1995).
To investigate whether dMEF2 activity stimulates 
the expression of the Mlp genes, we used an ectopic 
tissue-specific expression system (Brand and Perri- 
mon, 1993). Ectopic dMEF2 activity in the epidermis of 
germ band extended embryos is achieved using the 
GAL4 enhancer trap line 69B and a construct contain­
ing dMEF2 coding sequences downstream of the 
GAL4 recognition sites or UAS. dMEF2 is not nor­
mally found in this tissue, and ectopic expression 
leads to epidermal defects and subsequent embryonic 
lethality (Lin et al., 1997). We examined the possibility 
that ectopic expression of dMEF2 would result in up- 
regulation of muscle-specific targets such as the Mlps 
and myosin (Figure 3). In wild-type embryos under­
going muscle differentiation, myosin and the Mlps are 
observed in muscle tissues but not in epidermal cells 
(Figure 3, A-C); however, myosin expression is 
strongly induced in the epidermis by the presence of 
ectopic dMEF2 (Figure 3D). Mlp84B protein is also 
detected in the epidermis, concomitant with this ec­
topic expression of dMEF2 (Figure 3E). In contrast to 
both myosin and Mlp84B, Mlp60A  protein is not de­
tected at any appreciable level in epidermal cells of 
embryos that ectopically express dMEF2 (Figure 3F). 
We often observe a halo of staining in these embryos 
that is likely attributable to variable background asso­
ciated with the anti-Mlp60A  antibody. This staining 
does not appear cellular in nature, as that seen with 
the epidermal expression of myosin and Mlp84B, but 
rather as nonspecific surface staining.
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Figure 3. Ectopic dMEF2 expression stim­
ulates expression of myosin and Mlp84B 
but not Mlp60A. In wild-type embryos, my­
osin (A), Mlp84B (B), and Mlp60A (C) are 
detected by indirect immunofluorescence 
in embryonic somatic muscles (sm) but not 
epidermal cells (ep). Myosin (D) and 
Mlp84B (E) expression can be induced in 
the epidermis by ectopic expression of 
dMEF2 under the control of the 69B GAL4 
enhancer. Unlike myosin and Mlp84B, 
Mlp60A is not up-regulated by ectopic ex­
pression of epidermal dMEF2 (F). All pan­
els display lateral views of 12- to 14-h em­
bryos oriented with dorsal up and anterior 
to the left. Bar, 20 m.
W T GAL4 69B X UAS-dMEF2
To assess whether the Mlp60A  gene might require a 
higher threshold level of dMEF2 for its activation, we 
increased the dosage of dMEF2 in the epidermis by 
exploiting the temperature-sensitive nature of the 
GAL4 protein. At 29°C, GAL4 is reported to have 
higher activity resulting in greater accumulation of 
UAS-target gene product (Brand et al., 1994). Indeed, 
embryos raised at the higher temperature displayed 
more substantial phenotypic defects, suggesting in­
creased dMEF2 expression in the epidermis, but still 
did not show ectopic up-regulation of Mlp60A  protein 
(our unpublished results).
dMEF2 Binds Muscle LIM  Protein Gene Sequences 
In Vitro
To begin to address whether Mlps may require dMEF2 
activity directly for their expression, we analyzed the 
genomic sequences of the Mlp genes to identify poten­
tial dMEF2 binding sites. Figure 4A  displays the 
genomic organization of the Mlp60A  and Mlp84B 
genes denoting intron and exon structure. The Mlp60A 
gene exhibits three exons interrupted by two small 
introns, one in the 5 untranslated region and another 
in the coding region. The Mlp84B gene contains one
noncoding and one coding exon separated by a single 
large intron. Analysis of noncoding DNA within and 
surrounding the Mlp genes revealed the presence of 
multiple A/T-rich sequences matching exactly the re­
ported MEF2 target binding consensus sequence (Ol­
son et al., 1995). An alignment of the sites in the Mlp 
genes in comparison with the MEF2 consensus se­
quence and a bona fide mammalian MEF2 target se­
quence is displayed in Figure 4B. The Mlp60A  gene 
contains three potential dMEF2 binding sites; two of 
these sites are located in the region 5 to the start of 
gene, whereas the third is found 3 to the coding 
sequence. Six putative dMEF2 binding sites are found 
in the Mlp84B gene. Four of the six are clustered in the 
intron, another is located 3 to the coding region of the 
gene, and another is contained completely within the 
first exon.
One potential target site from each Mlp gene was 
chosen to test directly for dMEF2 binding activity in 
vitro, in parallel with a control site derived from the 
mammalian MCK gene (Gossett et al., 1989), which has 
been shown to bind dMEF2 in vitro (Lilly et al., 1994; 
Nguyen et al., 1994). Labeled oligonucleotides consist­
ing of the core MEF2 binding site flanked by three to
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Figure 4. dMEF2 protein binds to consensus MEF2 
sites found in the genomic regions of the Mlp genes. 
(A) Diagram of the genomic organization of the 
Mlp60A and Mlp84B genes. The boxed areas indicate 
the regions that correspond to cDNA sequences. The 
sticks indicate positions of 10-bp elements that exactly 
match the MEF2 consensus binding site. The two sites 
indicated by filled circles are those tested in the in 
vitro dMEF2 binding assay shown in C. The exact 
nucleotide range of the Mlp84B sites is noted in Gen- 
Bank accession number AF090832. (B) The potential 
MEF2 binding elements found in the putative regula­
tory regions of Mlp60A and Mlp84B are shown aligned 
with the MEF2 consensus, the MEF2 regulatory site 
from the MCK enhancer, and the Mutant 6 form of the 
MCK site, which does not support MEF2 binding. 
Letters to the left correspond to the sites diagrammed 
in A, and the filled letters indicate those sites tested in 
C. (C) Mobility shift assays with in vitro-translated 
dMEF2 protein were performed with oligonucleotides 
corresponding to the MCK MEF2 site and one MEF2 
element from each of the Mlp genes. The MEF2 ele­
ments used as probes were MCK MEF2 (lanes 1-6), 
Mlp60A-B (lanes 7-11), and Mlp84B-D (lanes 12-16). 
For each probe a control lysate lacking translated 
dMEF2 was included in parallel (lanes 1, 7, and 12). 
Competitor oligonucleotides were used at 100-fold 
molar excess of each probe. dMEF2 binds to each of 
the probes specifically (lanes 2, 8, and 13). Each of the 
Mlp MEF2 sites binds dMEF2 and competes for bind­
ing to the MCK element and their cognate site. A 
mutant form of the MCK element (Mutant 6) fails to 
compete for binding with any of the sites tested (lanes 
4, 11, and 16).
Probe:
7 8 9 10 11 
Mlp60A-B
12 13 14 15 16 
Mlp84B-D
eight additional nucleotides derived from genomic 
sequence were generated and used in electrophoretic 
gel mobility shift assays with in vitro-translated 
dMEF2 protein (Lilly et al., 1994). Figure 4C shows a 
shifted complex with each of the three probes (MCK, 
Mlp60A-B, and Mlp84B-D) dependent on the addition
of dMEF2 translation product. In addition, in all three 
cases, the bound probe could be efficiently competed 
by addition of excess unlabeled probe or an unlabeled 
control (MCK) probe. Furthermore, each of the shifted 
species was ineffectively competed by addition of ex­
cess unlabeled mutant probe, Mutant 6, in which a
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single base substitution within the MEF2 core binding 
site has been introduced (Cserjesi and Olson, 1991). 
Taken together, these results show that dMEF2 recog­
nizes and binds specifically and directly to sequences 
derived from the Mlp60A  and Mlp84B genes.
M yoblast Fusion Is Not Required fo r  Muscle LIM  
Protein Expression
Fusion of myoblasts into syncytial muscle fibers is a 
key feature of somatic muscle development in Dro­
sophila (Bate, 1990). Although the mechanism of fusion 
is not well understood, mutations that disrupt specific 
aspects of the process are beginning to be character­
ized. In Drosophila, embryos that harbor mutations in 
genes such as myoblast city (mbc) and rollingstone (rost) 
display severe defects in the process of myoblast fu­
sion such that many single unfused myoblasts persist 
late into embryogenesis after they would normally be 
incorporated into a growing muscle fiber (Paululat et 
al., 1995; Rushton et al., 1995). Previously, we noted 
that myoblast fusion precedes Mlp protein accumula­
tion by a few hours, suggesting that Mlps are not 
likely to be required for the fusion process (Stronach et 
al., 1996). However, the temporal relationship of fu­
sion events and Mlp expression raises the possibility 
that Mlp accumulation in the somatic lineage might 
depend on cell fusion. Furthermore, because fusion 
defects are also associated with mutations in dMEF2, 
we assessed the expression of Mlps in the rost mutant 
background in which a failure of myoblast fusion is 
the primary defect. In embryos mutant for the rost 
gene, both Mlp60A and Mlp84B are observed in single 
unfused myoblasts (Figure 5), distributed in charac­
teristic positions where, under normal circumstances, 
they would provide a pool of fusion competent cells 
for the developing syncytial myotubes (Bate, 1990). 
Thus, from these observations, we conclude that myo­
blast fusion is not required for Mlp expression, an 
observation that has also been noted for myosin and 
jB3 tubulin (Paululat et al., 1995; Rushton et al., 1995).
M lp84B Subcellular Distribution in Wild-Type and 
Mutant Visceral and Somatic Muscles
Knowledge of the subcellular distribution of a protein 
often contributes substantially to an understanding of its 
function. In embryonic somatic muscles, Mlp60A and 
Mlp84B are found in both the nuclear and cytoplasmic 
compartments, consistent with either a regulatory or 
structural role in differentiating muscle (Stronach et al.,
1996). When expressed in rat embryo fibroblast cells, 
Drosophila Mlps showed a specific association with the 
actin cytoskeleton (Stronach et al., 1996). To determine 
the precise localization of Mlps within mature myofibrils 
at higher resolution, we double-labeled whole, third in­
star larval midguts using antibodies directed against the 
Mlps and a-actinin, which marks Z-bands (Figure 6).
Mlp60A Mlp84B
Figure 5. Myoblast fusion is not required for muscle LIM protein 
expression. Immunofluorescent detection of Mlp60A (A and C) or 
Mlp84B (B and D) in embryos mutant for the rollingstone gene is 
shown. These embryos display severe defects in myoblast fusion. 
Both Mlps are expressed in single unfused myoblasts (mb) as well as 
in myotubes (mt) that have formed (see higher magnification; C and 
D). All panels display ventral-lateral views of late stage embryos 
with anterior to the left. Bars: A and B, 50 ptm; C and D, 20 ptm.
Surrounding the midgut, elongated visceral mesoder­
mal cells form a lattice of transverse and longitudinal 
fibers. Although these cells do not undergo myoblast 
fusion, they appear striated and display sarcomeric re­
peats (Saide et al., 1989; Tepass and Hartenstein, 1994). 
Within the midgut visceral mesoderm, -actinin promi­
nently localizes to Z-bands (Figure 6A). Z-bands demar­
cate the ends of individual sarcomeres (Figure 6D), 
where the barbed ends of actin thin filaments terminate. 
In the same tissue, Mlp84B distributes as a doublet that 
flanks each Z-band (Figure 6B). As seen in merged im­
ages (Figure 6C), -actinin and Mlp84B are localized in 
adjacent regions. Mlp84B extends away from the periph­
ery of the Z-band, whereas -actinin is clearly more 
restricted (Figure 6, C and D). The localization of Mlp84B 
to discrete sites within the muscle sarcomere provides 
evidence for a specific association of Mlp84B with the 
microfilament cytoskeleton in vivo. No nuclear staining 
for Mlp84B in the visceral muscles was observed at this 
time in development. Although Western immunoblot 
analysis revealed that Mlp60A is present in isolated mid­
gut preparations, we were unable to detect the protein 
using immunofluorescent methods. It is unclear why 
Mlp60A protein was not observed in situ, but perhaps 
within the mature myofibril, Mlp60A is complexed with 
protein partners such that the epitopes recognized by 
our antibodies are masked.
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Figure 6. Mlp84B localizes to discrete sites within sarcomeres of 
larval midgut visceral muscles. The mesoderm surrounding a third 
instar larval midgut has been double labeled for a-actinin (red), to 
visualize Z-bands, and Mlp84B (green). Most of the visceral muscles 
are positioned horizontally, but muscle cells can be seen on top of these 
positioned vertically in the figure. Mlp84B localizes as doublets within 
the muscles (B). In the merged image (C), Mlp84B is observed to flank 
a-actinin in a region adjacent to the Z-bands (see diagram of two 
adjacent sarcomeres with bands indicated in D). Bar, 10 ftm.
Effects o f a-Actinin Mutations on M lp84B Distribu­
tion. It has been reported that vertebrate CRP1 inter­
acts with a-actinin (Pomies et al., 1997). This interac­
tion may underlie the association of CRPs with the
microfilament cytoskeleton. By inference, Drosophila 
Mlps, relatives of the vertebrate CRPs, may associate 
with the cytoskeleton via interactions with -actinin. 
Although a-actinin and Mlp84B are not extensively 
colocalized, the distribution in adjacent domains may 
indicate that a subset of the molecules associate at the 
Z-band periphery. To evaluate whether Mlp84B local­
ization within sarcomeres depends on the presence of 
-actinin, we analyzed the distribution of Mlp84B in 
a-actinin mutant larval midguts. Mutant larvae be­
come progressively paralyzed and flaccid between 
hatching and the second instar molt. These larvae 
were dissected, and midguts were double labeled for 
Mlp84B and -actinin in parallel with similar staged 
wild-type larval midguts. Figure 7 illustrates compa­
rable Mlp84B localization in -actinin mutant versus 
wild-type midgut visceral muscles (Figure 7, compare 
B and D). Although mutant myofibers appear gener­
ally more disorganized than wild type, doublets of 
Mlp84B protein were observed in repeated arrays, 
reflecting some residual sarcomeric organization. 
Identical results were seen in four other -actinin mu­
tant backgrounds. Thus, in the absence of functional 
-actinin protein, Mlp84B is still capable of localizing 
to discrete sites within the developing sarcomeres. 
Therefore, -actinin is not absolutely essential for re­
cruiting Mlp84B to its normal subcellular location 
within muscle tissue. We do observe some inappro­
priate localization of Mlp84B in a-actinin-deficient 
muscles (Figure 7D). This may result from the decay­
ing muscle cytoarchitecture in the mutant or may 
reflect some contribution of -actinin in restricting 
Mlp84B localization.
Localization o f Mlp84B to Muscle Attachment Sites 
(MASs) Does Not Require PS2 Integrins. The identification 
of components required for normal Mlp84B localization 
may provide insight into its role in muscle differentiation. 
We noted previously that, in embryos, Mlp84B is enriched 
at the ends of somatic muscle fibers where they make 
attachments to the body wall. These attachment sites are 
thought to be analogous to the prominent focal adhesions 
of cultured fibroblast cells. Indeed, both focal adhesions 
and MASs are areas where actin filaments terminate at the 
membrane and become linked to extracellular matrix 
through a series of protein interactions culminating with 
the transmembrane integrin receptors (Burridge et al., 1988; 
Reedy and Beall, 1993; Tepass and Hartenstein, 1994). To 
confirm that the enrichment of Mlp84B at the ends of the 
somatic muscle fibers coincides with the location of the 
MAS, we double labeled embryos with antibodies directed 
against Mlp84B and the PS integrin subunit (Figure 8). PS 
forms a dimer with aPS2 in the muscle cell and with aPS1 in 
the neighboring tendon cell membrane (Bogaert et al., 1987; 
Leptin et al., 1989). As revealed in the merged image (Figure 
8C), significant colocalization of Mlp84B and PS was ob­
served at the MASs. Thus, we conclude that Mlp84B colo-
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Figure 7. Loss of a-actinin does 
not affect Mlp84B localization 
within visceral muscles. -Actinin 
null mutant l(1)HC288/Y and 
wild-type midgut muscles have 
been double labeled for -actinin 
(A and C) and Mlp84B (B and D). 
The null mutant lacks staining for 
-actinin protein (C), and wild 
type is shown for comparison (A). 
Note that Mlp84B distribution is 
similar in the wild-type (B) and 
mutant (D) visceral muscles 
showing doublets flanking the Z- 
bands. In the mutant, Mlp84B still 
localizes to discrete sites within 
sarcomeres. Bar, 10 m.
calizes with muscle integrin complexes. Integrin staining 
that was not coincident with Mlp84B was also observed in 
between the neighboring longitudinal muscles (Figure 8C, 
arrow), which may reflect the presence of PS complexes in 
the tendon cell membranes.
Colocalization of Mlp84B and PS integrin at MASs 
raises the possibility that integrin receptors, through 
interactions with extracellular ligands, recruit and sta­
bilize the association of Mlp84B with the junction and 
that this association is required for muscle develop­
ment or attachment. We sought to address the role of 
integrin receptor engagement in the recruitment of 
Mlp84B by analyzing the distribution of Mlp84B in an 
integrin mutant background. PS2 integrin mutations 
are lethal in part because of detachment of the muscles 
late in embryogenesis and subsequent failure of larvae 
to hatch from the eggshell (Wright, 1960). Using null 
alleles for both the PS subunit encoded by the myo- 
spheroid (mys) gene and the a PS2 subunit encoded by 
inflated (if (Leptin et al., 1989; Wilcox et al., 1989; 
Brown, 1994), we looked specifically for the presence 
of Mlp84B at the MASs of muscles in the mutant 
embryos (Figure 9). In both mys and if mutants, 
Mlp84B was observed at the junctional attachment 
sites in muscles before complete detachment or at 
remnant sites after detachment (Figure 9, C and E). 
Often we detected Mlp84B enriched at the membrane 
of muscles that appeared to be adhering end-to-end 
with one another (Figure 9, D and F). Therefore, 
Mlp84B localizes to MASs independent of PS2 inte- 
grin-ligand interactions. By staining mutant embryos 
with the anti- PS antibody, we detected no residual
integrin complexes containing the PS subunit that 
may have been contributed maternally (our unpub­
lished results).
D IS C U S S IO N
Key to understanding the process of muscle differen­
tiation is the characterization of myogenic regulatory 
factors and their molecular targets. Presumably, it is 
the unique combination of these target proteins that 
ultimately defines the differentiated morphology and 
function of distinct muscle types. In this study, we 
have described the results of molecular epistasis anal­
ysis designed to unravel mechanisms responsible for 
regulating Mlp gene expression during the process of 
myogenic differentiation and for establishing the sub- 
cellular distributions of Mlps within muscles. This 
analysis confirms that Mlps lie downstream of events 
involving mesoderm specification and patterning. Our 
findings indicate that Mlps are likely targets of tran­
scriptional regulation by a member of the MEF family 
of MADS (named for MCM-1, agamous, deficiens, and 
serum response factor) box myogenic transcription 
factors that regulate muscle differentiation. In addi­
tion, the process of myoblast fusion in the somatic 
muscle lineage is not required for Mlp expression. 
Furthermore, we demonstrate that Mlp84B associates 
specifically with the microfilament-based cytoskeleton 
within sarcomeres and that Mlp84B is enriched at the 
MASs in embryonic somatic muscles. The discrete 
localization of Mlp84B is not affected by loss of the
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Figure 8. Mlp84B colocalizes with £iPS integrin at the MASs. Ven­
tral-lateral longitudinal muscles of a stage 16 embryo are double 
labeled for Mlp84B (green) and the PS subunit of integrin (red). The 
merged image (C) reveals significant colocalization of the two pro­
teins (yellow) at the MASs. The arrow in C indicates PS complexes 
in the tendon cells. Bar, 20 m.
prominent Z-band protein a-actinin or the transmem­
brane PS2 integrin receptor.
Mlps Require dMEF2 Activity during Myogenesis
Many lines of evidence point to a role for CRP family 
members in muscle differentiation. To understand at 
what point in the differentiation program Mlps may 
function, we examined the interplay between dMEF2 
transcription factor function and Mlp expression. 
dMEF2 is an invertebrate member of a family of ver­
tebrate myocyte enhancer binding factors that display 
a MADS box and MEF2 domain, which promote DNA 
binding and dimerization (Nguyen et al., 1994; Olson 
et al., 1995). Cell biological and biochemical studies 
using vertebrate systems have implicated the MEF 
family of transcription factors in myogenesis, specifi­
cally in regulating muscle differentiation (Olson et al.,
1995). During Drosophila development, dMEF2 accu­
mulates in all muscle subtypes and displays a biphasic 
expression pattern suggesting a requirement for the 
protein in larval and adult myogenesis (Nguyen et al., 
1994; Bour et al., 1995; Ranganayakulu et al., 1995). 
Despite early expression of dMEF2 during gastrula- 
tion, genetic analysis revealed a role for the protein 
relatively late in the myogenic pathway. dMEF2 mu­
tant embryos display defective myoblast fusion and a 
failure of muscle differentiation (Bour et al., 1995; Lilly 
et al., 1995), consistent with the postulated role of 
vertebrate MEF2 proteins. Identification of the targets 
of dMEF2 has provided substantial insight into why 
differentiation fails in mutant embryos. dMEF2 activ­
ity regulates expression of several late markers that 
contribute to muscle structure and function. These 
include myosin, tropomyosin I, and the PS2 integrin 
(Ranganayakulu et al., 1995; Lin et al., 1996). Our find­
ings demonstrate clearly that dMEF2 is also essential 
for the expression of both Mlp60A  and Mlp84B in all 
of the muscle tissues in which they are normally ex­
pressed, because we observe no Mlp-positive cells in 
dMEF2 null mutant embryos. Indeed, in embryos ho­
mozygous for a severe hypomorphic allele of dMEF2 
(mef113) in which some nuclear dMEF2 protein can be 
detected (Ranganayakulu et al., 1995), we observed 
very weak expression of Mlp60A  and Mlp84B (our 
unpublished observations). This result supports the 
notion that Mlp genes may be sensitive to changes in 
the levels of dMEF2 transcriptional activity.
To investigate whether dMEF2 is capable of stimu­
lating Mlp expression, we used the GAL4-UAS system 
to express dMEF2 ectopically in the epidermis, a tissue 
in which it is not normally found. As a consequence of 
ectopic dMEF2 expression, we noted a robust up- 
regulation of myosin protein, a target of dMEF2. Sim­
ilarly, Mlp84B was induced in the epidermis. We did 
not observe Mlp60A  protein accumulation in epider­
mal cells that were programmed to express dMEF2. It 
is possible that either transcription from the Mlp60A 
gene is not initiated in the context of epidermal cells 
expressing dMEF2 or that protein is produced but 
then rapidly degraded. Consistent with the former 
hypothesis, Lin and colleagues (1997), using a similar 
dMEF2 overexpression system, failed to detect 
Mlp60A  transcripts by in situ hybridization in the 
embryonic epidermis, with the exception of several 
cells at the ventral midline. Perhaps the Mlp60A  gene 
is subject to different regulatory constraints than my­
osin and Mlp84B. For instance, Mlp60A  expression may 
be specifically repressed by an epidermal transcrip­
tional regulator or may lack a required coactivator 
present in mesoderm but not ectoderm. Collectively, 
these results indicate that Mlps may be members of a 
group of dMEF2 target proteins that contribute to 
differentiated muscle cytoarchitecture and function.
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Figure 9. Mlp84B is capable of associating with 
MASs in the absence of integrin-Ligand interac­
tions. Immunofluorescent detection of Mlp84B in 
somatic muscles of stage 16 wild-type (A and B), 
mys (C and D), or if  (E and F) embryos is shown. 
Note the characteristic rounded muscles observed 
in embryos mutant for either integrin subunit. 
Arrows indicate Mlp84B enrichment at the MASs 
of wild-type embryos (A and B) or at remnant 
junctions in mutant embryos (C-F). Bar, 20 /xm.
Interestingly, forced premature overexpression of 
dMEF2 in the mesoderm did not result in premature 
accumulation of Mlps in muscle tissue (our unpub­
lished observations). This observation implies that 
there are likely to be additional transcriptional regu­
latory inputs that converge at the Mlp gene promotors 
during myogenic development.
To explore whether the regulation of Mlp gene expres­
sion by dMEF2 could be direct, we searched the noncod­
ing regions of Mlp genomic DNA for potential dMEF2 
binding sites. Indeed, we identified several such se­
quences in both Mlp genes that matched exactly the 
reported consensus binding sites for MEF2 transcription 
factors (Olson et al., 1995). These putative binding sites 
are located in regions of the genes where regulatory
information, such as enhancer binding sites, are charac­
teristically found. We chose one putative site from each 
gene to test for dMEF2 binding in an in vitro binding 
assay. Labeled oligonucleotides derived from the 
Mlp60A and Mlp84B genes were directly and specifically 
bound by dMEF2 protein. Demonstration of candidate 
dMEF2 sites in the regulatory regions of the Mlp genes, 
coupled with the ability of a site from each gene to 
support specific binding of dMEF2 protein in vitro, sug­
gests that Mlps could be direct targets of dMEF2 activity 
in vivo. Definitive proof that Mlps are direct targets of 
dMEF2 will require further in vivo analysis of the MEF2 
sites present in the Mlp genes.
Our analysis of the genomic organization of the 
Mlps genes revealed an interesting finding. Although
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the Mlp60A gene encodes a protein with a single LIM 
domain, sequences 3 to the coding region appear to 
contain information that may have, at one time, en­
coded an additional four LIM domains. Perhaps an 
ancestral gene coding for a protein with five LIM 
domains gave rise to two Mlp genes, with the result 
that the Mlp84B gene was maintained to encode five 
domains, whereas the Mlp60A gene diverged and was 
corrupted to produce a truncated reading frame en­
coding a single LIM domain. It is also noteworthy that 
each of the two Mlp genes has a putative dMEF2 
binding site located just downstream of the gene and 
that these two sites appear to be related to each other. 
Otherwise, the genomic structure of these two genes 
appears to have significantly diverged.
Myoblast Fusion Is Not Required fo r  Mlp 
Expression
In addition to a failure of muscle differentiation, the 
process of myoblast fusion is also affected in dMEF2 
mutant embryos. To address whether the failure to 
accumulate Mlps is a result of defects in fusion, we 
analyzed Mlp expression in rost mutant embryos. In 
these embryos, unfused myoblasts persist well beyond 
the normal period of fusion and eventually express 
several differentiation markers including myosin 
(Paululat et al., 1995). We demonstrate that Mlps can 
also be expressed in single myoblasts in rost mutants. 
Thus, the defects in myoblast fusion resulting from 
mutations in dMEF2  do not appear to be the primary 
cause of the observed failure of Mlp expression in 
dMEF2 mutant embryos. Moreover, myoblast fusion 
does not appear to be a crucial checkpoint for ensuing 
muscle differentiation. Late in embryogenesis, these 
myoblast levels decline, presumably through an apo- 
ptotic mechanism coupled with macrophage-medi­
ated phagocytosis (Rushton et al., 1995). We have 
never detected Mlp expression in macrophages under 
normal conditions. However, it is possible that some 
Mlp-positive cells observed in the rost mutant em­
bryos represent phagocytic cells that have engulfed 
Mlp-expressing myoblasts.
Mlps Are Components of the Contractile Apparatus 
in Myofibrils
Vertebrate CRPs have been localized to the actin cy- 
toskeleton in certain cell types; CRP3/MLP gene dis­
ruption in the mouse leads to defects in cardiac muscle 
cytoarchitecture; and Drosophila Mlps are able to colo- 
calize with actin fibers in fibroblast cells (Arber et al., 
1994, 1997; Stronach et al., 1996; Louis et al., 1997). 
These observations point to a potential role for CRP 
family members in establishing muscle structure. In 
previous studies we noted the appearance of a linear 
staining pattern for Mlps in somatic myotubes in the 
embryo; however, it was not possible to assess clearly
the association of Mlps with subdomains of the micro­
filament cytoskeleton. Therefore, we turned to a later 
stage of development to examine the distribution of 
Mlps in relation to a mature sarcomeric pattern of 
striated muscle tissue. In the larva, a layer of striated 
visceral muscle cells encases the midgut and provides 
contractile activity to move food down the alimentary 
canal (Skaer, 1993). In these cells, we observed a 
highly localized distribution of Mlp84B protein in as­
sociation with the sarcomeric cytoskeleton. Specifi­
cally, Mlp84B was concentrated in double stripes 
flanking the Z-bands, which are rich in -actinin pro­
tein. To determine whether -actinin influences the 
localization of Mlp84B, we assessed the distribution of 
Mlp84B in muscles that fail to express -actinin. In 
-actinin mutant larval midguts, sarcomeres appear 
somewhat disorganized, but Mlp84B is localized nor­
mally. These data suggest that -actinin is not abso­
lutely essential for the proper recruitment of Mlp84B 
to the sarcomere. Because Mlp84B displays five copies 
of a protein-binding LIM-glycine motif, each of which 
may direct interactions with additional proteins 
within the contractile apparatus, it is possible that the 
lack of redistribution of Mlp84B in -actinin mutant 
muscles may reflect the involvement of multiple com­
ponents for Mlp84B localization. Interestingly, a sim­
ilar protein distribution has been noted for the actin 
capping protein tensin in cultured myotubes (Bock- 
holt et al., 1992), as well as for the vertebrate CRP3/ 
MLP isoform in mouse cardiomyocytes (Arber et al., 
1997). The comparable subcellular distributions of 
Mlp84B and CRP3/M LP in muscle cells points to a 
potential functional conservation among vertebrate 
and invertebrate CRP family members. Although the 
mechanism underlying Mlp84B localization is still un­
known, our data illustrate the specific association of 
Mlp84B with the microfilament cytoskeleton in vivo 
and lend support for a structural role for Mlp84B in 
mature differentiated muscles.
MAS Formation and Function
In striated muscles, Mlp84B localizes near regions en­
riched in the barbed, fast-growing ends of actin fila­
ments, such as the Z-band. In the developing embryo, 
Mlp84B accumulates at MASs where the barbed ends 
of actin filaments terminate at the membrane and as­
sociate with transmembrane integrin receptors. A l­
though Mlp84B and PS proteins are colocalized in 
vivo, in the absence of PS2 integrins, Mlp84B localizes 
appropriately. Both the normal muscle patterning and 
polarity seen in the integrin mutant embryos before 
muscle detachment and the ability of Mlp84B to local­
ize to the attachment sites in the absence of integrins 
suggest that integrin-ligand interactions are not in­
structive for defining the ends of the muscle fiber and 
assembling the attachment site. In further support of
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this notion, it is noteworthy that PS molecules, inca­
pable of binding extracellular ligands, also localize 
appropriately to MASs, results that place further em­
phasis on the importance of intracellular mechanisms 
for the organization of muscle termini (Martin- 
Bermudo and Brown, 1996). PS complexes appear to 
be necessary only for the continued maintenance of 
the attachment site once it has been assembled, an 
observation previously noted by careful analysis of 
the myospheroid phenotype (Wright, 1960).
Concluding Remarks
Using molecular epistasis methods, we have exam­
ined the relationships between Mlps and several gene 
products necessary for Drosophila myogenesis. This 
analysis revealed the dependence of Mlp gene expres­
sion on the transcriptional regulator dMEF2 and 
places Mlp function late in the terminal stages of mus­
cle differentiation. We show that myoblast fusion per 
se is not necessary for expression of the Mlp proteins 
and, furthermore, that neither -actinin nor PS2 inte- 
grin is required to direct Mlp84B to its proper position 
in muscle cells. Future work will continue to address 
the mode of Mlp gene regulation and their functional 
significance in the process of myogenesis. Genetic 
analysis of Mlp function is likely to provide important 
insights into their physiological roles in muscle. Thus 
far, no mutations in the Mlp60A gene have been iden­
tified, and deficiency analysis has been hampered by 
an apparent haploinsufficient locus in the region. 
However, we have begun to characterize phenotypes 
associated with loss of Mlp84B function. For this anal­
ysis, we have used a set of overlapping deficiencies 
that remove a small region of genomic DNA including 
the coding region of the Mlp84B gene. The Mlp84B- 
deficient animals die as larvae and early pupae, exhib­
iting locomotor and morphological defects consistent 
with abnormal muscle function (Clark and Beckerle, 
unpublished observations). Although additional work 
needs to be done to characterize fully the Mlp84B null 
phenotype, preliminary results suggest that gene func­
tion is essential for viability and proper muscle function.
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